This publication is intended for doctors and students of medicine. Every effort has been made to provide actual information, especially on medicine dosage, however, it is advisable that doctors make final decisions on their usage. It is not meant to replace a proper medical diagnosis or therapy. Responsibility taken by authors is suitable for this kind of publication and is not tantamount to responsibility for an individual medical advice. The Publisher has made every effort concerning reliability of the publication and the included information on the assortment, medicines and their prices. Yet the only legal information valid in the Republic of Poland are legal acts and in terms of trade – price offers of drugstores. As far as the information on medicines is concerned, the only lawful information is an updated characteristic of a medicinal substance and its producer’s leaflet.

The authors, consultants and publishers of this publication do not take any responsibility for possible mistakes or harms resulted from the information usage. Any cases of legal claims connected with medicines and chemical substances being under clinical examination are not going to be taken into consideration.

The Journal encourages you to share data that supports your research publication where appropriate. Research data refers to the results of observations or experimentation that validate research findings. If you are sharing data, you are encouraged to cite the data in your manuscript and reference list. If you have made your research data available in a data repository, you can link your article directly to the dataset thus giving readers access to underlying data that gives them a better understanding of the research described. There are different ways to link your datasets to your article. When available, you can directly link your dataset to your article by providing the relevant information in the submission system. 

Via Medica recommends the use of Mendeley Data, which enables you to deposit any research data (including raw and processed data, video, code, software, algorithms, protocols, and methods) associated with your manuscript in a free-to-use, open access repository. 

To exclude, even unintentional, plagiarism Cardiology Journal has introduced Ithenticate software, widely known in the academic community. All papers accepted for publication are now automatically screened within the manuscript system. Additionally, Editors may decide to run a similarity report at any other point during the review process or post-publication. Our Editorial team is aware of recognized limitation of this tool and realize that a high similarity score does not necessarily indicate plagiarized text. Thus, every doubtful report will be delt with individually to determine whether there are any grounds for concern.

The Cardiology Journal is published 6 times a year. Each new issue is published no later than on the last day of every second month.

The project on the development of the journal "Cardiology Journal" is co-financed from the state budget under the "Development of Scientific Journals" program as per the Regulation of the Minister of Education and Science of August 3, 2021 on the "Development of Scientific Journals" program (Journal of Laws of 2021, item Scientific Journals").

The total value of the project and co-financing from the state budget of PLN 38,000.

The project is implemented by VM Media Group sp. z o.o. based in Poland, with the head office in Gdańsk, under the agreement No. RCN/SN/0603/2021/1 concluded with the State Treasury – the Minister of Education and Science.

The aim of the project is to improve publishing and editing practices and to maintain the journal in international circulation.